Churchill Capital Corp VI (CCVI) 10-Q 17 Nov 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 16, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-40052
Entity Registrant Name	Churchill Capital Corp VI
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3391359
Entity Address, Address Line One	640 Fifth Avenue, 12th Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10019
City Area Code	212
Local Phone Number	380-7500
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001828250
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Transition Report	false
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-fifth of one warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock,$0.0001 par value, and one-fifth of one warrant
Trading Symbol	CCVI.U
Security Exchange Name	NYSE
Class A Common Stock
Document Information [Line Items]
Title of 12(b) Security	Shares of Class A common stock
Trading Symbol	CCVI
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		55,200,000
Warrants included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Warrants included as part of the units
Trading Symbol	CCVI WS
Security Exchange Name	NYSE
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		13,800,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)		Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash		$ 1,877,384	$ 25,000
Prepaid expenses		834,974
Total current assets		2,712,358	25,000
Deferred offering costs			55,000
Marketable securities held in Trust Account		552,035,810
TOTAL ASSETS		554,748,168	80,000
Current liabilities
Accrued expenses		618,082	1,000
Accrued offering costs			55,000
Total current liabilities		618,082	56,000
Warrant liabilities		30,657,600
Deferred underwriting fee payable		19,320,000
Total liabilities		50,595,682	56,000
Commitments and contingencies
Class A common stock subject to possible redemption, 55,200,000 and no shares at redemption value as of September 30, 2021 and December 31, 2020, respectively		552,000,000
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital			23,620
Accumulated deficit		(47,848,894)	(1,000)
Total stockholders' (deficit) equity		(47,847,514)	24,000
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY		554,748,168	80,000
Class A Common Stock Subject to Redemption
Current liabilities
Class A common stock subject to possible redemption, 55,200,000 and no shares at redemption value as of September 30, 2021 and December 31, 2020, respectively		552,000,000
Class B Common Stock
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Common stock	[1]	$ 1,380	$ 1,380
[1]	Included an aggregate of 1,800,000 shares that were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full at December 31, 2020 that was fully excercised at the IPO (see Note 6).

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Over-allotment option
Maximum shares subject to forfeiture	1,800,000	1,800,000
Class A Common Stock
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	500,000,000	500,000,000
Common shares, shares issued	55,200,000	0
Common shares, shares outstanding	55,200,000	0
Class A Common Stock Subject to Redemption
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	500,000,000	500,000,000
Temporary equity, shares outstanding	55,200,000	0
Class B Common Stock
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	100,000,000	100,000,000
Common shares, shares issued	13,800,000	13,800,000
Common shares, shares outstanding	13,800,000	13,800,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Operating costs	$ 841,110	$ 1,406,370
Loss from operations	(841,110)	(1,406,370)
Other income (expense):
Change in fair value of Warrant Liabilities	5,437,200	(5,798,400)
Transaction costs related to Private Placement and Public Warrants		(598,246)
Interest earned on marketable securities held in Trust Account	26,029	46,605
Unrealized gain (loss) on marketable securities held in Trust Account	16,116	(10,795)
Other income (expense), net	5,479,345	(6,360,836)
Net income (loss)	$ 4,638,235	$ (7,767,206)
Class A Common Stock
Other income (expense):
Basic weighted average shares outstanding, Non-redeemable common stock	55,200,000	45,494,505
Diluted weighted average shares outstanding, Non-redeemable common stock	55,200,000	45,494,505
Basic net loss per share, Non-redeemable common stock	$ 0.07	$ (0.13)
Diluted net loss per share, Non-redeemable common stock	$ 0.07	$ (0.13)
Class B Common Stock
Other income (expense):
Basic weighted average shares outstanding, Non-redeemable common stock	13,800,000	13,483,516
Diluted weighted average shares outstanding, Non-redeemable common stock	13,800,000	13,483,516
Basic net loss per share, Non-redeemable common stock	$ 0.07	$ (0.13)
Diluted net loss per share, Non-redeemable common stock	$ 0.07	$ (0.13)

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)	Class A Common Stock Subject to Redemption	Class A Common Stock Not Subject to RedemptionCommon Stock	Class B Common StockCommon Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020			$ 1,380	$ 23,620	$ (1,000)	$ 24,000
Balance at the beginning (in shares) at Dec. 31, 2020			13,800,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount	$ 40,104,308			(23,620)	(40,080,688)	(40,104,308)
Net loss					(4,138,081)	(4,138,081)
Balance at the end at Mar. 31, 2021			$ 1,380		(44,219,769)	(44,218,389)
Balance at the end (in shares) at Mar. 31, 2021		0	13,800,000
Balance at the beginning at Dec. 31, 2020			$ 1,380	$ 23,620	(1,000)	24,000
Balance at the beginning (in shares) at Dec. 31, 2020			13,800,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount						(40,104,308)
Net loss						(7,767,206)
Balance at the end at Sep. 30, 2021			$ 1,380		(47,848,894)	(47,847,514)
Balance at the end (in shares) at Sep. 30, 2021			13,800,000
Balance at the beginning at Mar. 31, 2021			$ 1,380		(44,219,769)	(44,218,389)
Balance at the beginning (in shares) at Mar. 31, 2021		0	13,800,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount	$ (6,335)				6,335	6,335
Net loss					(8,267,360)	(8,267,360)
Balance at the end at Jun. 30, 2021			$ 1,380		(52,480,794)	(52,479,414)
Balance at the end (in shares) at Jun. 30, 2021			13,800,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount					(6,335)	(6,335)
Net loss					4,638,235	4,638,235
Balance at the end at Sep. 30, 2021			$ 1,380		$ (47,848,894)	$ (47,847,514)
Balance at the end (in shares) at Sep. 30, 2021			13,800,000

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS	9 Months Ended
	Sep. 30, 2021USD ($)
Cash flows from operating activities:
Net loss	$ (7,767,206)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(46,605)
Unrealized loss on marketable securities held in Trust Account	10,795
Change in fair value of Warrant Liabilities	5,798,400
Transaction costs related to Private Placement and Public Warrants	598,246
Changes in operating assets and liabilities:
Prepaid expenses	(834,974)
Accrued expenses	617,082
Net cash used in operating activities	(1,624,262)
Cash flows from investing activities:
Investment of cash into Trust Account	(552,000,000)
Net cash used in investing activities	(552,000,000)
Cash flows from financing activities:
Proceeds from sale of Units, net of underwriting discounts paid	541,952,000
Proceeds from sale of Private Placements Warrants	14,040,000
Proceeds from promissory note - related party	175,000
Repayment of promissory note - related party	(175,000)
Payment of offering costs	(515,354)
Net cash provided by financing activities	555,476,646
Net change in cash	1,852,384
Cash - Beginning of period	25,000
Cash - End of period	1,877,384
Non-cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption	552,000,000
Deferred underwriting fee payable	19,320,000
Initial value of warrant liabilities	$ 24,859,200

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended
	Sep. 30, 2021
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Churchill Capital Corp VI (the “Company”) was incorporated in Delaware on October 9, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on February 11, 2021. On February 17, 2021, the Company consummated the Initial Public Offering of 55,200,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), including the issuance of 7,200,000 Units as a result of the underwriters’ full exercise of their over-allotment option further described in Note 4. The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $552,000,000. Simultaneously with the closing of the IPO, the Company consummated the sale of 14,040,000 warrants (the “Private Placement Warrants”) at a purchase price of $1.00 per Private Placement Warrant, to the Company’s sponsor, Churchill Sponsor VI LLC (the “Sponsor”), generating gross proceeds to the Company of $14,040,000. Transaction costs amounted to $29,883,354 consisting of $10,048,000 of net underwriting discount, $19,320,000 of deferred underwriting discount and $515,354 of other offering costs. Following the closing of the Initial Public Offering on February 17, 2021, an amount of $552,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended, (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below, except that interest earned on the Trust Account can be released to the Company to fund working capital requirements, subject to an annual limit of  $1,000,000 and to pay its tax obligations. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding net of amounts disbursed to management for working capital purposes, if applicable, taxes payable on interest income earned from the Trust Account and the deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares in connection with a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest, net of permitted withdrawals). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law or stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor and its permitted transferees have agreed to vote their Founder Shares (as defined in Note 6) and any Public Shares acquired during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, public stockholders may elect to redeem their Public Shares, irrespective of whether they vote for or against the proposed Business Combination. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and the Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its rights to liquidating distributions from the Trust Account with respect to its Founder Shares if the Company fails to consummate a Business Combination within the Combination Window (as defined below) and (c) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem one-hundred percent (100%) of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering (or 27 months from the closing of the Initial Public Offering if the Company has an executed letter of intent, agreement in principle or definitive agreement for a Business Combination within 24 months from the closing of the Initial Public Offering) (the “Combination Window”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten ( 10 The Sponsor has agreed to waive its right to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Window. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Window. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Window and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the funds on deposit in the Trust Account remaining available for distribution will be less than the Initial Public Offering price per Unit of $10.00 in the Initial Public Offering. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement, reduce the amount of funds on deposit in the Trust Account to below (i) $10.00 per Public Share or (ii) the amount per Public Share held in the Trust Account as of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, in each case, net of permitted withdrawals. This liability will not apply with respect to any claims by a third party that executed a waiver of any and all rights to seek access to the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Company due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target business, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2021
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS In connection with the preparation of the Company's condensed financial statements as of September 30, 2021 and in accordance with the SEC and its staff’s guidance on redeemable equity instruments, ASC 480, paragraph 10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Accordingly, management determined it should restate its previously reported condensed financial statements. The Company had previously determined the shares of Class A Common Stock subject to possible redemption to be equal to the redemption value of $10.00 per share of Class A Common Stock while also taking into consideration that a redemption cannot result in net tangible assets being less than $5,000,001. Management has also determined that the shares of Class A Common Stock issued in connection with the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management has concluded that the redemption value should include all the shares of Class A Common Stock subject to possible redemption, resulting in the shares of Class A Common Stock subject to possible redemption being equal to their redemption value. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the changes and has determined that the related impact was material to previously presented financial statements. As a result, management has noted a restatement related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the shares of Class A Common Stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and the shares of Class A Common Stock. There has been no change in the Company’s total assets, liabilities or operating results. The impact of the restatement on the Company’s financial statements is reflected in the following table: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ ​ ​ Balance Sheet as of February 17, 2021 (audited) Reported Adjustment As Restated Class A common stock subject to possible redemption ​ $ 506,321,440 ​ $ 45,678,560 ​ $ 552,000,000 Class A common stock ​ $ 457 ​ $ (457) ​ $ — Additional paid-in capital ​ $ 5,597,664 ​ $ (5,597,664) ​ $ — Accumulated deficit ​ $ (599,246) ​ $ (40,080,439) ​ $ (40,679,685) Total stockholders’ equity (deficit) ​ $ 5,000,006 ​ $ (45,678,560) ​ $ (40,678,554) Number of shares subject to redemption ​ ​ 50,632,144 ​ ​ 4,567,856 ​ ​ 55,200,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance Sheet as of March 31, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Class A common stock subject to possible redemption ​ $ 502,781,610 ​ $ 49,218,390 ​ $ 552,000,000 Class A common stock ​ $ 492 ​ $ (492) ​ $ — Additional paid-in capital ​ $ 9,137,210 ​ $ (9,137,210) ​ $ — Accumulated deficit ​ $ (4,139,081) ​ $ (40,080,688) ​ $ (44,219,769) Total stockholders’ equity (deficit) ​ $ 5,000,001 ​ $ (49,218,390) ​ $ (44,218,389) Number of shares subject to redemption ​ ​ 50,278,161 ​ ​ 4,921,839 ​ ​ 55,200,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance Sheet as of June 30, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Class A common stock subject to possible redemption ​ $ 494,514,245 ​ $ 57,479,420 ​ $ 551,993,665 Class A common stock ​ $ 575 ​ $ (575) ​ $ — Additional paid-in capital ​ $ 17,404,492 ​ $ (17,404,292) ​ $ — Accumulated deficit ​ $ (12,406,441) ​ $ (40,074,353) ​ $ (52,480,794) Total stockholders’ equity (deficit) ​ $ 5,000,006 ​ $ (57,479,420) ​ $ (52,479,414) Number of shares subject to redemption ​ ​ 49,451,992 ​ ​ 5,748,008 ​ ​ 55,200,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Condensed Statement of Changes in Stockholders’ Equity (Deficit) as of March 31, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Sale of 55,200,000 Units, net of underwriting discounts and offering expenses ​ $ 511,895,692 ​ $ (511,895,692) ​ $ — Initial value of common stock subject to redemption at IPO ​ $ (506,321,440) ​ $ 506,321,440 ​ $ — Change in value of common stock subject to redemption ​ $ 3,539,830 ​ $ (3,539,830) ​ $ — Accretion for Class A common stock to redemption amount ​ $ — ​ $ (40,104,308) ​ $ (40,104,308) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Condensed Statement of Changes in Stockholders’ Equity (Deficit) as of June 30, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Change in value of common stock subject to redemption ​ $ 8,267,365 ​ $ (8,267,365) ​ $ — Accretion for Class A common stock to redemption amount ​ $ — ​ $ 6,335 ​ $ 6,335 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Statement of Cash Flows for the Three Months Ended March 31, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Initial classification of Class A common stock subject to possible redemption ​ $ 506,321,440 ​ $ 45,678,560 ​ $ 552,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Statement of Cash Flows for the Six Months Ended June 30, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Initial classification of Class A common stock subject to possible redemption ​ $ 506,321,440 ​ $ 45,978,560 ​ $ 552,000,000 ​ In connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its income (loss) per common share calculated to allocate net income (loss) evenly to Class A and Class B common stock. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of common stock share pro rata in the income (loss) of the Company. There is no impact to the reported amounts for total assets, total liabilities, cash flows, or net income (loss). The impact of this restatement on the Company’s financial statements is reflected in the following table: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ As Previously ​ ​ As Previously ​ ​ ​ ​ Reported ​ As Restated ​ Reported ​ As Restated ​ Reported ​ As Restated ​ ​ For the Three ​ For the Three ​ For the Three ​ For the Three ​ For the Six ​ For the Six ​ ​ Months Ended ​ Months Ended ​ Months Ended ​ Months Ended ​ Months Ended ​ Months Ended ​ ​ March 31, 2021 ​ March 31, 2021 ​ June 30, 2021 ​ June 30, 2021 ​ June 30, 2021 ​ June 30, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption ​ 50,632,144 ​ — ​ 50,278,161 ​ — ​ 50,389,945 ​ — Basic and diluted net loss per common share, Class A common stock ​ $ — ​ $ — ​ $ — ​ $ — ​ $ — ​ $ — Basic and diluted weighted average shares outstanding, Class B common ​ 14,971,666 ​ — ​ 18,721,839 ​ — ​ 16,857,112 ​ — Basic and diluted net loss per common share, Class B common stock ​ $ (0.28) ​ $ — ​ $ (0.44) ​ $ — ​ $ (0.74) ​ $ — Weighted average shares outstanding of Class A common stock ​ — ​ 25,760,000 ​ — ​ 55,200,000 ​ — ​ 40,561,326 Basic and diluted net income (loss) income per share, Class A common stock ​ $ — ​ $ (0.11) ​ $ — ​ $ (0.12) ​ $ — ​ $ (0.23) Weighted average shares outstanding of Class B common stock ​ — ​ 12,840,000 ​ — ​ 13,800,000 ​ — ​ 13,322,652 Basic and diluted net income (loss) per share, Class B common stock ​ $ — ​ $ (0.11) ​ $ — ​ $ (0.12) ​ $ — ​ $ (0.23) ​

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on February 12, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ended December 31, 2021 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a registration statement under the Securities Act declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020. Marketable Securities Held in the Trust Account At September 30, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. No amounts were withdrawn during the nine months ended September 30, 2021. The Company did not have any assets held in the Trust Account at December 31, 2020. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in the Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At September 30, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 552,000,000 Less: ​ Proceeds Allocated to Public Warrants ​ $ (10,819,200) Class A common stock issuance costs ​ $ (29,285,108) Plus: ​ Accretion of carrying value to redemption value ​ $ 40,104,308 ​ ​ ​ ​ Class A common stock subject to possible redemption ​ $ 552,000,000 ​ Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 4) and the Private placement Warrants (collectively, the “Warrants”) in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statements of operations. The Public Warrants and Private Placement Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation and a modified Black-Scholes model, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. As of September 30, 2021 all deferred tax assets resulting from net operating losses were fully offset by a valuation allowance. Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounted to $29,883,354, of which $29,285,108 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $598,246 were expensed to the condensed statements of operations. Net Income (Loss) per Common Share Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating net income (loss) per common share. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value. The calculation of diluted income (loss) per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement to purchase an aggregate of 25,080,000 shares of common stock in the calculation of diluted income (loss) per common share, since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could potentially be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ September 30, 2021 ​ September 30, 2021 ​ ​ Class A ​ Class B ​ Class A ​ Class B Basic and diluted net income (loss) per common share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net loss, as adjusted ​ $ 3,710,588 ​ $ 927,647 ​ $ (5,991,472) ​ $ (1,775,734) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic diluted average shares ​ ​ 55,200,000 ​ ​ 13,800,000 ​ ​ 45,494,505 ​ ​ 13,483,516 Basic diluted per common ​ $ 0.07 ​ $ 0.07 ​ $ (0.13) ​ $ (0.13) ​ Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the Company’s derivative instruments (see Note 10). Recent Accounting Standards In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have an impact on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

PUBLIC OFFERING

PUBLIC OFFERING	9 Months Ended
	Sep. 30, 2021
PUBLIC OFFERING
PUBLIC OFFERING	NOTE 4. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 55,200,000 Units, at a purchase price of $10.00 per Unit, which includes the full exercise by the underwriter of its option to purchase an additional 7,200,000 Units at $10.00 per Unit. Each Unit consists of one share of Class A common stock and one

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended
	Sep. 30, 2021
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 14,040,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $14,040,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Window, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants (see Note 9).

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2021
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares In December 2020, the Sponsor purchased 11,500,000 shares of the Company’s Class B common stock for an aggregate price of $25,000 (the “Founder Shares” or, individually, a “Founder Share”). On February 11, 2021, the Company effected a stock dividend of one-fifth of a one Founder Share for each outstanding Founder Share, resulting in our initial stockholders holding an aggregate of 13,800,000 Founder Shares. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one (1) year after the completion of a Business Combination and (B) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or similar transaction after a Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any twenty (20) trading days within any thirty (30)-trading day period commencing at least one-hundred fifty (150) days after a Business Combination, the Founder Shares will be released from the lock-up. Administrative Support Agreement The Company entered into an agreement, commencing on February 11, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, pursuant to which the Company will pay an affiliate of the Sponsor a total of $30,000 per month for office space, administrative and support services. For the three and nine months ended September 30, 2021, the Company incurred and paid $90,000 and $221,786 of such fees, respectively. Advisory Fee The Company may engage M. Klein and Company, LLC, an affiliate of the Sponsor, or another affiliate of the Sponsor, as its lead financial advisor in connection with a Business Combination and may pay such affiliate a customary financial advisory fee in an amount that constitutes a market standard financial advisory fee for comparable transactions. Promissory Note — Related Party On December 22, 2020, the Sponsor agreed to loan the Company an aggregate of up to $600,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note is non-interest bearing and payable on the earlier of December 31, 2021 or the completion of the Initial Public Offering. As of September 30, 2021 and December 31, 2020, there was no outstanding balance under the Promissory Note. The borrowings outstanding under the Promissory Note in the amount of $175,000 were repaid upon the consummation of the Initial Public Offering on February 17, 2021. Borrowings under the Promissory Note are no longer available. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. These warrants would be identical to the Private Placement Warrants.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2021
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 7. COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement (the “Registration Rights Agreement”) to be signed prior to or on the effective date of the Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion into shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders of these securities have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering our securities. The Company will bear the expenses incurred in connection with the filing of any such registration statement. Underwriting Agreement The Company granted the underwriters a forty-five (45)-day option from the date of Initial Public Offering to purchase up to 7,200,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter’s election to fully exercise the over-allotment option to purchase an additional 7,200,000 Units, at a price of $10.00 per Unit. The underwriters waived the upfront underwriting discount on 4,960,000 Units, resulting in a reduction of the upfront underwriting discount of $992,000. The underwriters are entitled to a deferred fee of $0.35 per Unit, or $19,320,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement. Due Diligence Fees As of September 30, 2021, the Company incurred due diligence fees of $300,000. These fees will only become due and payable upon the consummation of an initial Business Combination. Legal Fees As of September 30, 2021, the Company incurred legal fees of $12,000. These fees will only become due and payable upon the consummation of an initial Business Combination.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2021
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS’ DEFICIT Preferred Stock — Class A Common Stock outstanding issued Class B Common Stock Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of the Class B common stock will automatically convert into the shares of Class A common stock at the time of the completion of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of the Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of the Class B common stock shall convert into shares of the Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of the Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of the Class A common stock issuable upon conversion of all shares of the Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of the Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, any private placement-equivalent warrants issued, or to be issued, to any seller in a Business Combination. ​

WARRANT LIABILITIES

WARRANT LIABILITIES	9 Months Ended
	Sep. 30, 2021
WARRANT LIABILITIES
WARRANT LIABILITIES	NOTE 9. WARRANT LIABILITIES As of September 30, 2021, there were 11,040,000 Public Warrants outstanding. There were no Public Warrants outstanding as of December 31, 2020. The Public Warrants may only be exercised for a whole number of shares. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Public Warrants will become exercisable on the later of (a) thirty (30) days after the completion of a Business Combination or (b) twelve (12) months from the closing of the Initial Public Offering. The Public Warrants will expire five (5) years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Warrant and will have no obligation to settle such exercise unless a registration statement under the Securities Act covering the issuance of the shares of the Class A common stock issuable upon exercise of the Warrants is then effective and a current prospectus relating to those shares of the Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of the Class A common stock issuable upon exercise of the Warrants and to maintain a current prospectus relating to those shares of the Class A common stock until the Warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Warrants who exercise their Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its reasonable best efforts to qualify the shares of the Class A common stock under applicable blue sky laws to the extent an exemption is not available. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than thirty ( 30 ) days’ prior written notice of redemption; ● if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any twenty ( 20 ) trading days within a thirty ( 30 )-trading day period ending on the third business day prior to the notice of redemption to the Public Warrant holders; and ● if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the Public Warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Window and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. As of September 30, 2021, there were 14,040,000 Private Placement Warrants outstanding. There were no Private Placement Warrants outstanding as of December 31, 2020. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until thirty (30) days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2021
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 10. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30,2021 and at Issuance (upon consummation of the IPO) and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ At Issuance ​ ​ ​ September 30, ​ February 11, Description ​ Level ​ 2021 ​ 2021 Assets: ​ ​ ​ ​ Marketable securities held in Trust Account 1 ​ $ 552,035,810 ​ $ 552,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ Warrant liability – Public Warrants ​ 1 ​ ​ 13,248,000 ​ ​ — Warrant liability – Public Warrants ​ 3 ​ ​ — ​ ​ 10,819,200 Warrant liability – Private Placement Warrants 3 ​ ​ 17,409,600 ​ ​ 14,040,000 ​ The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are measured at fair value at inception and on a recurring basis, with changes in fair value recorded in the statements of operations. As of September 30, 2021, the Warrant Liability for Private Placement Warrants was valued using a modified Black-Scholes model, which is considered to be a Level 3 fair value measurement. At issuance, the Public Warrants were valued using a Monte Carlo simulation. Subsequent to the Public Warrants detachment from the Units, the Public Warrants are valued based on quoted market price, under ticker CCVI. WS, which is a Level 1 fair value measurement. The Monte Carlo simulation’s primary unobservable input utilized in determining the fair value of the Warrants is the probability of consummation of the Business Combination. The probability assigned to the consummation of the Business Combination was 80% which was estimated based on the observed success rates of business combinations for special purpose acquisition companies. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. At issuance, the estimated fair value of the Private Placement Warrants and the estimated fair value of the Public Warrants was determined by a Monte Carlo simulation. As of September 30, 2021, the estimated fair value of the Private Placement Warrants was determined using a modified Black-Scholes model. The following are the significant inputs used in determining fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of ​ At Issuance ​ ​ September 30, 2021 February 11, 2021 Exercise price ​ $ 11.50 ​ $ 11.50 ​ Stock price ​ $ 9.77 ​ $ 9.81 ​ Volatility ​ 18.3 % 19.25 % Probability of completing a Business Combination ​ 80 % 80 % Term ​ 5.27 ​ 5.25 ​ Risk-free rate ​ 1.14 % 0.69 % Dividend yield ​ 0.0 % 0.0 % ​ The following table presents the changes in the fair value of Level 3 warrant liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrants ​ Private Placement Warrants ​ Warrant Liabilities Warrant liabilities at February 17, 2021 (IPO) ​ $ — ​ $ — ​ $ — Issuance of Public and Private Warrants ​ ​ 10,819,200 ​ ​ 14,040,000 ​ 24,859,200 Change in fair value of warrant liabilities ​ ​ 1,435,200 ​ ​ 1,965,600 ​ ​ 3,400,800 Fair value as of March 31, 2021 ​ ​ 12,254,400 ​ ​ 16,005,600 ​ ​ 28,260,000 Change in fair value of warrant liabilities ​ ​ 3,201,600 ​ ​ 4,633,200 ​ ​ 7,834,000 Transfer to Level 1 ​ ​ (15,456,000) ​ ​ — ​ ​ (15,456,000) Fair value as of June 30, 2021 ​ $ — ​ $ 20,638,800 ​ $ 20,638,800 Change in fair value of warrant liabilities ​ ​ — ​ ​ (3,229,200) ​ ​ (3,229,200) Fair value as of September 30, 2021 ​ $ — ​ $ 17,409,600 ​ $ 17,409,600 ​ Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement at the time of transfer during the nine months ended September 30, 2021 was $15,456,000.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2021
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company’s management has evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on February 12, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the year ended December 31, 2021 or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a registration statement under the Securities Act declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.
Marketable Securities Held in the Trust Account	Marketable Securities Held in the Trust Account At September 30, 2021, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. No amounts were withdrawn during the nine months ended September 30, 2021. The Company did not have any assets held in the Trust Account at December 31, 2020. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in the Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At September 30, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 552,000,000 Less: ​ Proceeds Allocated to Public Warrants ​ $ (10,819,200) Class A common stock issuance costs ​ $ (29,285,108) Plus: ​ Accretion of carrying value to redemption value ​ $ 40,104,308 ​ ​ ​ ​ Class A common stock subject to possible redemption ​ $ 552,000,000 ​
Warrant Liabilities	Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 4) and the Private placement Warrants (collectively, the “Warrants”) in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statements of operations. The Public Warrants and Private Placement Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation and a modified Black-Scholes model, respectively. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. As of September 30, 2021 all deferred tax assets resulting from net operating losses were fully offset by a valuation allowance.
Offering Costs	Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounted to $29,883,354, of which $29,285,108 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $598,246 were expensed to the condensed statements of operations.
Net Income (Loss) per Common Share	Net Income (Loss) per Common Share Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. The Company applies the two-class method in calculating net income (loss) per common share. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value. The calculation of diluted income (loss) per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement to purchase an aggregate of 25,080,000 shares of common stock in the calculation of diluted income (loss) per common share, since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could potentially be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ September 30, 2021 ​ September 30, 2021 ​ ​ Class A ​ Class B ​ Class A ​ Class B Basic and diluted net income (loss) per common share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net loss, as adjusted ​ $ 3,710,588 ​ $ 927,647 ​ $ (5,991,472) ​ $ (1,775,734) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic diluted average shares ​ ​ 55,200,000 ​ ​ 13,800,000 ​ ​ 45,494,505 ​ ​ 13,483,516 Basic diluted per common ​ $ 0.07 ​ $ 0.07 ​ $ (0.13) ​ $ (0.13)
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the Company’s derivative instruments (see Note 10).
Recent Accounting Standards	Recent Accounting Standards In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have an impact on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Sep. 30, 2021
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Schedule of the impact of the revision on the Company's financial statements	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ ​ ​ ​ ​ Balance Sheet as of February 17, 2021 (audited) Reported Adjustment As Restated Class A common stock subject to possible redemption ​ $ 506,321,440 ​ $ 45,678,560 ​ $ 552,000,000 Class A common stock ​ $ 457 ​ $ (457) ​ $ — Additional paid-in capital ​ $ 5,597,664 ​ $ (5,597,664) ​ $ — Accumulated deficit ​ $ (599,246) ​ $ (40,080,439) ​ $ (40,679,685) Total stockholders’ equity (deficit) ​ $ 5,000,006 ​ $ (45,678,560) ​ $ (40,678,554) Number of shares subject to redemption ​ ​ 50,632,144 ​ ​ 4,567,856 ​ ​ 55,200,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance Sheet as of March 31, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Class A common stock subject to possible redemption ​ $ 502,781,610 ​ $ 49,218,390 ​ $ 552,000,000 Class A common stock ​ $ 492 ​ $ (492) ​ $ — Additional paid-in capital ​ $ 9,137,210 ​ $ (9,137,210) ​ $ — Accumulated deficit ​ $ (4,139,081) ​ $ (40,080,688) ​ $ (44,219,769) Total stockholders’ equity (deficit) ​ $ 5,000,001 ​ $ (49,218,390) ​ $ (44,218,389) Number of shares subject to redemption ​ ​ 50,278,161 ​ ​ 4,921,839 ​ ​ 55,200,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Balance Sheet as of June 30, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Class A common stock subject to possible redemption ​ $ 494,514,245 ​ $ 57,479,420 ​ $ 551,993,665 Class A common stock ​ $ 575 ​ $ (575) ​ $ — Additional paid-in capital ​ $ 17,404,492 ​ $ (17,404,292) ​ $ — Accumulated deficit ​ $ (12,406,441) ​ $ (40,074,353) ​ $ (52,480,794) Total stockholders’ equity (deficit) ​ $ 5,000,006 ​ $ (57,479,420) ​ $ (52,479,414) Number of shares subject to redemption ​ ​ 49,451,992 ​ ​ 5,748,008 ​ ​ 55,200,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Condensed Statement of Changes in Stockholders’ Equity (Deficit) as of March 31, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Sale of 55,200,000 Units, net of underwriting discounts and offering expenses ​ $ 511,895,692 ​ $ (511,895,692) ​ $ — Initial value of common stock subject to redemption at IPO ​ $ (506,321,440) ​ $ 506,321,440 ​ $ — Change in value of common stock subject to redemption ​ $ 3,539,830 ​ $ (3,539,830) ​ $ — Accretion for Class A common stock to redemption amount ​ $ — ​ $ (40,104,308) ​ $ (40,104,308) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Condensed Statement of Changes in Stockholders’ Equity (Deficit) as of June 30, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Change in value of common stock subject to redemption ​ $ 8,267,365 ​ $ (8,267,365) ​ $ — Accretion for Class A common stock to redemption amount ​ $ — ​ $ 6,335 ​ $ 6,335 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Statement of Cash Flows for the Three Months Ended March 31, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Initial classification of Class A common stock subject to possible redemption ​ $ 506,321,440 ​ $ 45,678,560 ​ $ 552,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Statement of Cash Flows for the Six Months Ended June 30, 2021 (unaudited) ​ ​ ​ ​ ​ ​ ​ ​ ​ Initial classification of Class A common stock subject to possible redemption ​ $ 506,321,440 ​ $ 45,978,560 ​ $ 552,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As Previously ​ ​ As Previously ​ ​ As Previously ​ ​ ​ ​ Reported ​ As Restated ​ Reported ​ As Restated ​ Reported ​ As Restated ​ ​ For the Three ​ For the Three ​ For the Three ​ For the Three ​ For the Six ​ For the Six ​ ​ Months Ended ​ Months Ended ​ Months Ended ​ Months Ended ​ Months Ended ​ Months Ended ​ ​ March 31, 2021 ​ March 31, 2021 ​ June 30, 2021 ​ June 30, 2021 ​ June 30, 2021 ​ June 30, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption ​ 50,632,144 ​ — ​ 50,278,161 ​ — ​ 50,389,945 ​ — Basic and diluted net loss per common share, Class A common stock ​ $ — ​ $ — ​ $ — ​ $ — ​ $ — ​ $ — Basic and diluted weighted average shares outstanding, Class B common ​ 14,971,666 ​ — ​ 18,721,839 ​ — ​ 16,857,112 ​ — Basic and diluted net loss per common share, Class B common stock ​ $ (0.28) ​ $ — ​ $ (0.44) ​ $ — ​ $ (0.74) ​ $ — Weighted average shares outstanding of Class A common stock ​ — ​ 25,760,000 ​ — ​ 55,200,000 ​ — ​ 40,561,326 Basic and diluted net income (loss) income per share, Class A common stock ​ $ — ​ $ (0.11) ​ $ — ​ $ (0.12) ​ $ — ​ $ (0.23) Weighted average shares outstanding of Class B common stock ​ — ​ 12,840,000 ​ — ​ 13,800,000 ​ — ​ 13,322,652 Basic and diluted net income (loss) per share, Class B common stock ​ $ — ​ $ (0.11) ​ $ — ​ $ (0.12) ​ $ — ​ $ (0.23)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Summary of reconciliation of common stock subject to possible redemption	At September 30, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 552,000,000 Less: ​ Proceeds Allocated to Public Warrants ​ $ (10,819,200) Class A common stock issuance costs ​ $ (29,285,108) Plus: ​ Accretion of carrying value to redemption value ​ $ 40,104,308 ​ ​ ​ ​ Class A common stock subject to possible redemption ​ $ 552,000,000
Schedule of calculation of basic and diluted net income (loss) per common share	The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Nine Months Ended ​ ​ September 30, 2021 ​ September 30, 2021 ​ ​ Class A ​ Class B ​ Class A ​ Class B Basic and diluted net income (loss) per common share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net loss, as adjusted ​ $ 3,710,588 ​ $ 927,647 ​ $ (5,991,472) ​ $ (1,775,734) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic diluted average shares ​ ​ 55,200,000 ​ ​ 13,800,000 ​ ​ 45,494,505 ​ ​ 13,483,516 Basic diluted per common ​ $ 0.07 ​ $ 0.07 ​ $ (0.13) ​ $ (0.13)

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2021
FAIR VALUE MEASUREMENTS
Schedule of company's assets that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30,2021 and at Issuance (upon consummation of the IPO) and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ At Issuance ​ ​ ​ September 30, ​ February 11, Description ​ Level ​ 2021 ​ 2021 Assets: ​ ​ ​ ​ Marketable securities held in Trust Account 1 ​ $ 552,035,810 ​ $ 552,000,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ Warrant liability – Public Warrants ​ 1 ​ ​ 13,248,000 ​ ​ — Warrant liability – Public Warrants ​ 3 ​ ​ — ​ ​ 10,819,200 Warrant liability – Private Placement Warrants 3 ​ ​ 17,409,600 ​ ​ 14,040,000
Schedule of quantitative information regarding fair value measurements inputs	At issuance, the estimated fair value of the Private Placement Warrants and the estimated fair value of the Public Warrants was determined by a Monte Carlo simulation. As of September 30, 2021, the estimated fair value of the Private Placement Warrants was determined using a modified Black-Scholes model. The following are the significant inputs used in determining fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of ​ At Issuance ​ ​ September 30, 2021 February 11, 2021 Exercise price ​ $ 11.50 ​ $ 11.50 ​ Stock price ​ $ 9.77 ​ $ 9.81 ​ Volatility ​ 18.3 % 19.25 % Probability of completing a Business Combination ​ 80 % 80 % Term ​ 5.27 ​ 5.25 ​ Risk-free rate ​ 1.14 % 0.69 % Dividend yield ​ 0.0 % 0.0 %
Schedule of change in the fair value of the warrant liabilities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrants ​ Private Placement Warrants ​ Warrant Liabilities Warrant liabilities at February 17, 2021 (IPO) ​ $ — ​ $ — ​ $ — Issuance of Public and Private Warrants ​ ​ 10,819,200 ​ ​ 14,040,000 ​ 24,859,200 Change in fair value of warrant liabilities ​ ​ 1,435,200 ​ ​ 1,965,600 ​ ​ 3,400,800 Fair value as of March 31, 2021 ​ ​ 12,254,400 ​ ​ 16,005,600 ​ ​ 28,260,000 Change in fair value of warrant liabilities ​ ​ 3,201,600 ​ ​ 4,633,200 ​ ​ 7,834,000 Transfer to Level 1 ​ ​ (15,456,000) ​ ​ — ​ ​ (15,456,000) Fair value as of June 30, 2021 ​ $ — ​ $ 20,638,800 ​ $ 20,638,800 Change in fair value of warrant liabilities ​ ​ — ​ ​ (3,229,200) ​ ​ (3,229,200) Fair value as of September 30, 2021 ​ $ — ​ $ 17,409,600 ​ $ 17,409,600

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)	Feb. 17, 2021USD ($)$ / sharesshares	Mar. 31, 2021shares	Sep. 30, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)
Subsidiary, Sale of Stock [Line Items]
Sale of 55,200,000 Units, net of underwriting discount and offering expenses (in shares) | shares		55,200,000
Purchase price, per unit | $ / shares			$ 10
Proceeds from sale of Private Placements Warrants			$ 14,040,000
Transaction Costs	$ 29,883,354
Net underwriting fees	10,048,000
Deferred underwriting fee payable	19,320,000		19,320,000
Other offering costs	$ 515,354
Cash held outside the trust account			1,877,384	$ 25,000
Payments for investment of cash in trust account			$ 552,000,000
Condition for future business combination use of proceeds percentage			80
Condition For Future Business Combination Threshold Percentage Ownership			50
Condition For Future Business Combination Threshold Net Tangible Assets			$ 5,000,001
Redemption limit percentage without prior consent			15
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)			100.00%
Months to complete acquisition			24 months
Redemption period upon closure			10 days
Maximum allowed dissolution expenses			$ 100,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of 55,200,000 Units, net of underwriting discount and offering expenses (in shares) | shares	55,200,000		7,200,000
Purchase price, per unit | $ / shares	$ 10
Proceeds from issuance initial public offering	$ 552,000,000
Deferred underwriting fee payable			$ 19,320,000
Cash held outside the trust account	1,000,000
Payments for investment of cash in trust account	$ 552,000,000
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares			14,040,000
Price of warrant | $ / shares			$ 1
Proceeds from sale of Private Placements Warrants			$ 14,040,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of 55,200,000 Units, net of underwriting discount and offering expenses (in shares) | shares	7,200,000		7,200,000
Purchase price, per unit | $ / shares	$ 10

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - USD ($)		3 Months Ended			6 Months Ended	9 Months Ended
		Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021	Feb. 17, 2021	Dec. 31, 2020
Balance sheet
Class A ordinary share subject to possible redemption		$ 552,000,000	$ 551,993,665	$ 552,000,000	$ 551,993,665	$ 552,000,000
Additional paid-in capital								$ 23,620
Accumulated deficit		(47,848,894)	(52,480,794)	(44,219,769)	(52,480,794)	(47,848,894)	$ (40,679,685)	(1,000)
Total stockholders' equity (deficit)		(47,847,514)	$ (52,479,414)	$ (44,218,389)	$ (52,479,414)	(47,847,514)	$ (40,678,554)	$ 24,000
Number of shares subject to redemption			55,200,000	55,200,000	55,200,000		55,200,000
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Accretion for Class A common stock to redemption amount		6,335	$ (6,335)	$ 40,104,308		40,104,308
Initial value of common stock subject to redemption at IPO						552,000,000
Sale of 55,200,000 Units, net of underwriting discount and offering expenses (in shares)				55,200,000
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption						552,000,000
Class A Common Stock Subject to Redemption
Balance sheet
Class A ordinary share subject to possible redemption		$ 552,000,000				$ 552,000,000	$ 552,000,000
Number of shares subject to redemption		55,200,000				55,200,000		0
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Accretion for Class A common stock to redemption amount			6,335	$ (40,104,308)
Initial value of common stock subject to redemption at IPO				552,000,000	$ 552,000,000
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption				552,000,000	552,000,000
Class B Common Stock
Balance sheet
Class A common stock	[1]	$ 1,380				$ 1,380		$ 1,380
As Previously Reported | Restatement of redeemable common stock as temporary equity
Balance sheet
Class A ordinary share subject to possible redemption			494,514,245	502,781,610	494,514,245
Class A common stock			575	492	575
Additional paid-in capital			17,404,492	9,137,210	17,404,492		5,597,664
Accumulated deficit			(12,406,441)	(4,139,081)	(12,406,441)		(599,246)
Total stockholders' equity (deficit)			$ 5,000,006	$ 5,000,001	$ 5,000,006		$ 5,000,006
Number of shares subject to redemption			49,451,992	50,278,161	49,451,992		50,632,144
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Sale of 55,200,000 Units, net of underwriting discount and offering expenses				$ 511,895,692
Change in value of common stock subject to redemption			$ 8,267,365	3,539,830
Initial value of common stock subject to redemption at IPO				(506,321,440)
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption				(506,321,440)
As Previously Reported | Class A Common Stock | Restatement of redeemable common stock as temporary equity
Balance sheet
Class A common stock							$ 457
As Previously Reported | Class A Common Stock Subject to Redemption | Restatement of redeemable common stock as temporary equity
Balance sheet
Class A ordinary share subject to possible redemption							506,321,440
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Initial value of common stock subject to redemption at IPO				506,321,440	$ 506,321,440
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption				506,321,440	506,321,440
Adjustment | Restatement of redeemable common stock as temporary equity
Balance sheet
Class A ordinary share subject to possible redemption			57,479,420	49,218,390	57,479,420
Class A common stock			(575)	(492)	(575)
Additional paid-in capital			(17,404,292)	(9,137,210)	(17,404,292)		(5,597,664)
Accumulated deficit			(40,074,353)	(40,080,688)	(40,074,353)		(40,080,439)
Total stockholders' equity (deficit)			$ (57,479,420)	$ (49,218,390)	$ (57,479,420)		$ (45,678,560)
Number of shares subject to redemption			5,748,008	4,921,839	5,748,008		4,567,856
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Sale of 55,200,000 Units, net of underwriting discount and offering expenses				$ (511,895,692)
Change in value of common stock subject to redemption			$ (8,267,365)	(3,539,830)
Initial value of common stock subject to redemption at IPO				506,321,440
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption				506,321,440
Adjustment | Class A Common Stock | Restatement of redeemable common stock as temporary equity
Balance sheet
Class A common stock							$ (457)
Adjustment | Class A Common Stock Subject to Redemption | Restatement of redeemable common stock as temporary equity
Balance sheet
Class A ordinary share subject to possible redemption							$ 45,678,560
Condensed Statement of Changes in Stockholders' Equity (Deficit)
Accretion for Class A common stock to redemption amount			$ 6,335	(40,104,308)
Initial value of common stock subject to redemption at IPO				45,678,560	$ 45,978,560
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption				$ 45,678,560	$ 45,978,560
[1]	Included an aggregate of 1,800,000 shares that were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full at December 31, 2020 that was fully excercised at the IPO (see Note 6).

RESTATEMENT OF PREVIOUSLY ISS_4

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Additional Information (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 17, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Minimum net tangible assets	$ 5,000,001
Purchase price, per unit	$ 10
Total stockholders' equity (deficit)	$ (47,847,514)	$ (52,479,414)	$ (44,218,389)	$ (40,678,554)	$ 24,000
Class A ordinary share subject to possible redemption	$ 552,000,000	551,993,665	552,000,000
As Previously Reported | Restatement of redeemable common stock as temporary equity
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity (deficit)		5,000,006	5,000,001	5,000,006
Class A ordinary share subject to possible redemption		494,514,245	502,781,610
Adjustment | Restatement of redeemable common stock as temporary equity
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total stockholders' equity (deficit)		(57,479,420)	(49,218,390)	$ (45,678,560)
Class A ordinary share subject to possible redemption		$ 57,479,420	$ 49,218,390

RESTATEMENT OF PREVIOUSLY ISS_5

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Impact of the restatement on the Companys financial statements (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Class A Common Stock Subject to Redemption | As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	50,278,161	50,632,144	50,389,945
Class A Common Stock Not Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	55,200,000	25,760,000	40,561,326
Basic and diluted net loss per common share	$ (0.12)	$ (0.11)	$ (0.23)
Class B Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	13,800,000	12,840,000	13,322,652
Basic and diluted net loss per common share	$ (0.12)	$ (0.11)	$ (0.23)
Class B Common Stock | As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted weighted average shares outstanding	18,721,839	14,971,666	16,857,112
Basic and diluted net loss per common share	$ (0.44)	$ (0.28)	$ (0.74)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Amount withdrawn from trust account	$ 0
Unrecognized tax benefits	0	$ 0
Unrecognized tax benefits accrued for interest and penalties	0	$ 0
Offering costs	29,883,354
Offering costs charged to shareholders' equity	29,285,108
Offering cost allocable to Warrant Liabilities	$ 598,246
Anti-dilutive securities attributable to warrants (in shares)	25,080,000
Federal Depository Insurance Corporation coverage limit	$ 250,000

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of common stock subject to possible redemption (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Gross proceeds				$ 552,000,000
Proceeds Allocated to Public Warrants				(10,819,200)
Class A common stock issuance costs				(29,285,108)
Accretion for Class A common stock to redemption amount	$ 6,335	$ (6,335)	$ 40,104,308	40,104,308
Class A common stock subject to possible redemption	$ 552,000,000	$ 551,993,665	$ 552,000,000	$ 552,000,000

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Calculation of basic and diluted net income (loss) per common share (Details) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021
Class A Common Stock
Numerator:
Allocation of net loss, as adjusted	$ 3,710,588				$ (5,991,472)
Denominator:
Basic weighted average shares outstanding	55,200,000				45,494,505
Diluted weighted average shares outstanding	55,200,000				45,494,505
Basic net income (loss) per common share	$ 0.07				$ (0.13)
Diluted net income (loss) per common share	$ 0.07				$ (0.13)
Class B Common Stock
Numerator:
Allocation of net loss, as adjusted	$ 927,647				$ (1,775,734)
Denominator:
Basic weighted average shares outstanding	13,800,000				13,483,516
Diluted weighted average shares outstanding	13,800,000				13,483,516
Basic net income (loss) per common share	$ 0.07				$ (0.13)
Diluted net income (loss) per common share	$ 0.07				$ (0.13)
Basic and diluted weighted average shares outstanding		13,800,000	12,840,000	13,322,652
Basic and diluted net loss per common share		$ (0.12)	$ (0.11)	$ (0.23)

PUBLIC OFFERING (Details)

PUBLIC OFFERING (Details) - $ / shares	Feb. 17, 2021	Mar. 31, 2021	Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Number of units sold		55,200,000
Purchase price, per unit			$ 10
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units sold	55,200,000		7,200,000
Purchase price, per unit	$ 10
Initial Public Offering | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit	1
Number of warrants in a unit	0.2
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units sold	7,200,000		7,200,000
Purchase price, per unit	$ 10

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details)	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price | $	$ 14,040,000
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued | shares	14,040,000
Price of warrants | $ / shares	$ 1
Aggregate purchase price | $	$ 14,040,000
Number of shares per warrant | shares	1
Exercise price of warrant | $ / shares	$ 11.50

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details) - Sponsor - Class B Common Stock	Feb. 11, 2021D$ / sharesshares	Dec. 31, 2020USD ($)shares	Sep. 30, 2021shares
Related Party Transaction [Line Items]
Number of shares issued		11,500,000
Aggregate purchase price | $		$ 25,000
Aggregate number of shares owned	13,800,000
Shares subject to forfeiture			0
Restrictions on transfer period of time after business combination completion	1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares	$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D	20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D	30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences	150 days

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)	Feb. 11, 2021	Dec. 22, 2020	Sep. 30, 2021	Sep. 30, 2021
Related Party Transaction [Line Items]
Repayment of promissory note - related party				$ 175,000
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note		$ 600,000
Outstanding balance of related party note			$ 0	0
Repayment of promissory note - related party		$ 175,000
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month	$ 30,000
Expenses incurred and paid			90,000	221,786
Related Party Loans
Related Party Transaction [Line Items]
Loan conversion agreement warrant			$ 1,500,000	$ 1,500,000
Related Party Loans | Working capital loans warrant
Related Party Transaction [Line Items]
Price of warrant			$ 1	$ 1

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	Feb. 17, 2021USD ($)itemshares	Mar. 31, 2021shares	Sep. 30, 2021USD ($)$ / sharesshares
Subsidiary or Equity Method Investee [Line Items]
Number of units sold | shares		55,200,000
Maximum number of demands for registration of securities | item	3
Diligence Fees			$ 300,000
Deferred fee per unit | $ / shares			$ 0.35
Deferred underwriting fee payable	$ 19,320,000		$ 19,320,000
Underwriter cash discount			4,960,000
Aggregate underwriter cash discount			992,000
Legal fees incurred			$ 12,000
Initial Public Offering
Subsidiary or Equity Method Investee [Line Items]
Number of units sold | shares	55,200,000		7,200,000
Deferred underwriting fee payable			$ 19,320,000
Over-allotment option
Subsidiary or Equity Method Investee [Line Items]
Number of units sold | shares	7,200,000		7,200,000
Granted Term			45 days
Share Price | $ / shares			$ 10

STOCKHOLDERS' DEFICIT - Preferr

STOCKHOLDERS' DEFICIT - Preferred Stock Shares (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
STOCKHOLDERS' DEFICIT
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

STOCKHOLDERS' DEFICIT - Common

STOCKHOLDERS' DEFICIT - Common Stock Shares (Details)	9 Months Ended
	Sep. 30, 2021Vote$ / sharesshares	Jun. 30, 2021shares	Mar. 31, 2021shares	Feb. 17, 2021shares	Dec. 31, 2020Vote$ / sharesshares
Class of Stock [Line Items]
Number of shares subject to redemption		55,200,000	55,200,000	55,200,000
Class A Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	500,000,000				500,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001				$ 0.0001
Common shares, shares issued (in shares)	55,200,000				0
Common shares, shares outstanding (in shares)	55,200,000				0
Class A Common Stock Subject to Redemption
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	500,000,000				500,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001				$ 0.0001
Common shares, votes per share | Vote	1				1
Number of shares subject to redemption	55,200,000				0
Class B Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	100,000,000				100,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001				$ 0.0001
Common shares, votes per share | Vote	1				1
Common shares, shares issued (in shares)	13,800,000				13,800,000
Common shares, shares outstanding (in shares)	13,800,000				13,800,000
Ratio to be applied to the stock in the conversion	20

WARRANT LIABILITIES (Details)

WARRANT LIABILITIES (Details)	9 Months Ended
	Sep. 30, 2021D$ / sharesshares	Dec. 31, 2020shares
Warrants
Class of Warrant or Right [Line Items]
Maximum period after business combination in which to file registration statement	15 days
Threshold Period For Registration Statement To Be Effective After Which Warrants Can Be Exercised On Cashless Basis	60 days
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding | shares	14,040,000	0
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding | shares	11,040,000	0
Warrant exercise period condition one	30 days
Warrant exercise period condition two	12 months
Public Warrants expiration term	5 years
Warrant redemption condition minimum share price | $ / shares	$ 18
Redemption price per public warrant (in dollars per share) | $ / shares	$ 0.01
Threshold trading days for redemption of public warrants | D	20
Threshold consecutive trading days for redemption of public warrants | D	30
Redemption period	30 days
Restrictions on transfer period of time after business combination completion	30 days

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021	Feb. 11, 2021
Assets:
Marketable securities held in Trust Account	$ 552,035,810
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	30,657,600
Level 1
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities		$ 15,456,000
Level 1 | Public Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	15,456,000	$ 15,456,000
Level 1 | Recurring
Assets:
Marketable securities held in Trust Account	552,035,810		$ 552,000,000
Level 1 | Recurring | Public Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	13,248,000
Level 3 | Recurring | Public Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities			10,819,200
Level 3 | Recurring | Private Placement Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant liabilities	$ 17,409,600		$ 14,040,000

FAIR VALUE MEASUREMENTS - Level

FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details) - Level 3	Sep. 30, 2021$ / shares	Feb. 11, 2021$ / shares
Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	11.50	11.50
Stock price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	9.77	9.81
Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	18.3	19.25
Probability of completing a Business Combination
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	80	80
Term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	5.27	5.25
Risk-free rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	1.14	0.69
Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0	0

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)	1 Months Ended	3 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Jun. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Warrant liabilities at February 17, 2021 (IPO)	$ 0	$ 20,638,800	$ 28,260,000
Issuance of Public and Private Warrants	24,859,200
Change in fair value of warrant liabilities	3,400,800	(3,229,200)	7,834,000
Transfer to Level 1		(30,657,600)
Fair value as of September 30, 2021	28,260,000	17,409,600	20,638,800
Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Warrant liabilities at February 17, 2021 (IPO)	0		12,254,400
Issuance of Public and Private Warrants	10,819,200
Change in fair value of warrant liabilities	1,435,200		3,201,600
Fair value as of September 30, 2021	12,254,400
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Warrant liabilities at February 17, 2021 (IPO)	0	20,638,800	16,005,600
Issuance of Public and Private Warrants	14,040,000
Change in fair value of warrant liabilities	1,965,600	(3,229,200)	4,633,200
Fair value as of September 30, 2021	$ 16,005,600	17,409,600	20,638,800
Level 1
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfer to Level 1			(15,456,000)
Level 1 | Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfer to Level 1		$ (15,456,000)	$ (15,456,000)